Thoughts About the Economics of Health Policies

Abstract

Given nursing’s interest in health policies, the authors present a discussion of costs associated with health policies. Three examples of these costs are adolescent use of vaping and e-cigarettes, international guidelines for hypertension diagnosis and treatment, and medical aid in dying.

Keywords

economics health policies nursing

Get full access to this article

View all access options for this article.

References

American Association for Cancer Research. (2020, June 10). Cancer care costs in the United States are projected to exceed $245 billion by 2030. https://www.aacr.org/about-the-aacr/newsroom/news-releases/cancer-care-costs-in-the-united-states-are-projected-to-exceed-245-billion-by2030/#:~:text=Cost%20estimates%20were%20inflated%20to,corresponding%20to%20%24105%2C500%20per%20patient

Birdsey

Cornelius

Jamal

Park-Lee

Cooper

M. R.

Wang

Sawdey

M. D.

Cullen

K. A.

Neff

(2023, November 3). Tobacco product use among US middle and high school students—National Youth Tobacco Survey, 2023. Morbidity and Mortality Weekly Report, 72(44), 1173-1182. https://doi.org/10.15585/mmwr.mm7244a1.

Bouthillier

M.-E.

Perron

Roigt

Fortin

J.-S.

Pimont

(2022). The implementation of assisted dying in Quebec and interdisciplinary support groups: What role for ethics? HEC Forum, 34(4), 355-369. https://doi.org/10.1007/s10730-022-09484-w

Centers for Disease Control and Prevention. (2023). Tobacco product use among US middle and high school students—National Youth Tobacco Survey, 2023. https://www.cdc.gov/mmwr/volumes/72/wr/mm7244a1.htm

Compassion and Choices. (2024). Medical aid in dying: A policy to improve care and expand options life’s end. In Medical aid-in-dying utilization report (pp. 19-23). https://www.compassionandchoices.org/resource/medical-aid-in-dying-utilization-report

Davari

Sorato

M. M.

Kebriaeezadeh

Sarrafzadegan

(2022). Cost-effectiveness of hypertension therapy based on 2020 International Society of Hypertension guidelines in Ethiopia from a societal perspective. PLoS One, 17(8), e0273439. https://doi.org/10.1371/journal.pone.0273439

Duncan

Ahmed

Dove

Maxwell

T. L.

(2019). Medicare cost at end of life. American Journal of Hospice and Palliative Medicine, 36(8), 705-710. https://doi.org/10.1177/1049909119836204

Food and Drug Administration. (2023). FY 2023 FDA budget summary fact sheet. https://www.fda.gov/media/157193/download

French

Jones

J. B.

Kelly

McCauley

(2018). End-of-life medical expenses. Federal Reserve Bank of Richmond Working Papers, 18(18), 1-38. https://doi.org/10.21144/wp18-18

10.

Fujioka

J. K.

Mirza

R. M.

McDonald

P. L.

Klinger

C. A.

(2018). Implementation of medical assistance in dying: A scoping review of health care providers’ perspectives. Journal of Pain and Symptom Management, 55(6), 1564-1576.e9. https://doi.org/10.1016/j.jpainsymman.2018.02.011

11.

Grube

Cardenas

(2017). Insurance coverage and aid-in-dying medication costs. JAMA Oncology, 3(8), 1137. https://doi.org/10.1001/jamaoncol.2016.6585

12.

Higginson

I. J.

Johnston

B. M.

Ryan

McQuillan

Selman

Pantilat

S. Z.

Daveson

B. A.

Morrison

R. S.

Normand

(2020). Associations between informal care costs, care quality, carer rewards, burden and subsequent grief: The International, Access, Rights and Empowerment mortality follow-back study of the last 3 months of life (IARE I study). BMC Medicine, 18(1), 344-344. https://doi.org/10.1186/s12916-020-01768-7

13.

International Society of Hypertension. (2023). Our corporate members, global partners, and affiliated societies. https://ish-world.com/our-partners/

14.

Kinghorn

Coast

(2019). Appropriate frameworks for economic evaluation of end of life care: A qualitative investigation with stakeholders. Palliative Medicine, 33(7), 823-831. https://doi.org/10.1177/0269216319839635

15.

Kusmaul

Becker

T. D.

Gibson

Wallace

C. L.

(2023, June 22). Medical aid in dying: How might US policy prevent suffering at the end of life? Journal of Aging & Social Policy, 36(5), 1-18. https://doi.org/10.1080/08959420.2023.2226306

16.

Nguyen

H. Q.

Gelman

E. J.

Bush

T. A.

Lee

J. S.

Kanter

M. H.

(2018). Characterizing Kaiser Permanente Southern California’s experience with the California End of Life Option Act in the first year of implementation. JAMA Internal Medicine, 178(3), 417-421. https://doi.org/10.1001/jamainternmed.2017.7728

17.

Porche

D. J.

(2023). Health policy: Application for nurses and other healthcare professionals (3rd ed.). Jones & Bartlett Learning.

18.

Short

(2019). Overview: The economics and finance of health care. In Milstead

J. A.

Short

N. M.

(Eds.), Health policy and politics: A nurse’s guide (6th ed., pp. 171-192). Jones & Bartlett Learning.

19.

Treem

(2023). Medical aid in dying: Ethical and practical issues. Journal of the Advanced Practitioner in Oncology, 14(3), 207-211. https://doi.org/10.6004/jadpro.2023.14.3.5

20.

Unger

Borghi

Charchar

Khan

N. A.

Poulter

N. R.

Prabhakaran

Ramirez

Schlaich

Stergiou

G. S.

Tomaszewski

Wainford

R. D.

Williams

Schutte

A. E.

(2020). 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension, 75(6), 1334-1357. https://doi.org/10.1161/HYPERTENSIONAHA.120.15026

21.

Woodcock

(2021). An epidemic continues: Youth vaping in America. US Food and Drug Administration. https://www.fda.gov/news-events/congressional-testimony/epidemic-continues-youth-vaping-america-06232021